InNexus Biotechnology, Inc.
IXSBF
$0.00
$0.000.00%
OTC PK
| 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 523.08% | 6,540.00% | -63.16% | -99.63% | -80.74% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -81.38% | -- | -94.66% | -90.93% | -84.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 78.17% | 30.03% | -84.17% | -95.85% | -95.51% |
|
|
|||||
| Total Current Assets | 78.17% | 30.03% | -84.17% | -95.85% | -95.51% |
| Net Property, Plant & Equipment | -60.58% | -55.20% | -53.60% | -49.97% | -9.67% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -99.60% | -99.58% | -8.11% | -23.13% | 10,067.47% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 3.98% | 9.64% | -- |
| Total Assets | -18.50% | -16.67% | -20.93% | -19.54% | -4.73% |
|
|
|||||
| Total Accounts Payable | -3.95% | -5.73% | -7.55% | 1.93% | 6.87% |
| Total Accrued Expenses | 54.25% | 36.24% | -41.61% | -2.45% | 13.96% |
| Short-term Debt | -- | 56.62% | 44.47% | 175.80% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 119.69% | 60.61% | 58,025.81% | 137,760.87% | 756,025.00% |
| Total Finance Division Other Current Liabilities | 26.06% | 27.85% | 27.49% | 35.92% | 115.64% |
| Total Other Current Liabilities | 26.06% | 27.85% | 27.49% | 35.92% | 115.64% |
| Total Current Liabilities | 19.91% | 36.83% | 87.39% | 133.00% | 228.79% |
|
|
|||||
| Total Current Liabilities | 19.91% | 36.83% | 87.39% | 133.00% | 228.79% |
| Long-Term Debt | -- | 145.52% | -84.85% | -- | -- |
| Short-term Debt | -- | 56.62% | 44.47% | 175.80% | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 23.29% | 39.07% | 26.98% | 42.24% | 49.65% |
|
|
|||||
| Common Stock & APIC | -11.09% | 12.38% | 17.87% | 24.44% | 36.32% |
| Retained Earnings | -18.99% | -24.22% | -26.23% | -37.34% | -59.50% |
| Treasury Stock & Other | 285.49% | 33.37% | 16.60% | 37.14% | -- |
| Total Common Equity | -64.79% | -122.73% | -99.69% | -186.28% | -233.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -64.79% | -122.73% | -99.69% | -186.28% | -233.71% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 3.85% | 5.33% | 4.11% | -82.38% | -83.75% |
| Total Equity | -64.91% | -123.07% | -99.95% | -193.12% | -246.90% |
|
|
|||||